Among the 144 patients carrying a BRAF mutated melanoma in our series (Figure 1), 61 DNA samples (30 cases evaluated by SS assay and 31 by pyrosequencing) were selected as adequate for further analyses. This evidence concerns the gene BRAF and melanoma.